Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04474457 |
|
Recruitment Status : Unknown
Verified January 2021 by Prof. Ates KARA, MD, Hacettepe University.
Recruitment status was: Active, not recruiting
First Posted : July 16, 2020
Last Update Posted : February 1, 2021
|
Sponsor:
Ministry of Health, Turkey
Collaborators:
Hacettepe University, School of Medicine
Prof. Dr. Cemil Tascıoglu City Hospital
Umraniye Training and Research Hospital
Istanbul Training and Research Hospital
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Tepecik Training and Research Hospital
Istanbul University - Cerrahpasa (IUC)
Ankara University
Ankara City Hospital Bilkent
Ankara Training and Research Hospital
Ege University Hospital (Application and Research Center)
Derince Training and Research Hospital
Istanbul University
Kayseri City Hospital
Information provided by (Responsible Party):
Prof. Ates KARA, MD, Hacettepe University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Actual Primary Completion Date : | December 31, 2020 |
| Estimated Study Completion Date : | June 1, 2021 |